Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality

Journal of the National Cancer Institute

Volumn 93, Issue 10, 2001, Pages 754-762

  O'Meara, Ellen S ^a   Rossing, Mary Anne ^a   Daling, Janet R ^a   Elmore, Joann G ^a   Barlow, William E ^a   Weiss, Noel S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; DIENESTROL; ESTRADIOL; ESTROGEN DERIVATIVE; ETHINYLESTRADIOL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0035897534     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.10.754     Document Type: Article

References (46)

1. Estrogen replacement therapy in breast cancer survivors. A time for change
2. Estrogen replacement therapy for breast cancer patients
3. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk
4. Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk
5. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women
6. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women
7. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors
8. Symptoms associated with tamoxifen treatment in postmenopausal women
9. Nonhormonal alternatives for the management of early menopause in younger women with breast cancer
10. Hormone replacement therapy and nonhormonal control of menopausal symptoms in breast cancer survivors
11. Treatment of estrogen deficiency symptoms in women surviving breast cancer
12. A clinical dilemma: Estrogen replacement therapy in postmenopausal women with a background of primary breast cancer
13. Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial
14. A controlled trial of raloxifene (LY139481) HCI: Impact on bone turnover and serum lipid profile in healthy postmenopausal women
15. A chronic disease score from automated pharmacy data
16. A chronic disease score with empirically derived weights
17. Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women
18. Breast
19. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture
20. On the significance of in situ production of oestrogens in human breast cancer tissue
21. Estrogen levels in postmenopausal women with hot flashes
22. Healthy screenee bias in epidemiologic studies of cancer incidence
23. Hormone replacement therapy in women treated for breast cancer
24. Hormone replacement after breast cancer
25. Hormone replacement therapy in previously treated breast cancer patients
26. Estrogen replacement therapy in women with prior diagnosis and treatment for breast cancer
27. An experience with estrogen replacement therapy in breast cancer survivors
28. Estrogen replacement therapy in breast cancer survivors
29. A case-control study of combined continuous estrogen-progestin replacement therapy among women with a personal history of breast cancer
30. Hormone replacement therapy in breast cancer survivors: A cohort study
31. Estrogen replacement therapy in women with previous breast cancer
32. Estrogen replacement therapy after localized breast cancer: Clinical outcome of 319 women followed prospectively
33. A case-control study of hormone replacement therapy after primary surgical breast cancer treatment
34. Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies
35. Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer
36. Low biologic aggressiveness in breast cancer in women using hormone replacement therapy
37. Breast carcinoma developing in patients on hormone replacement therapy: A histological and immunohistological study
38. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other modes of delivery
39. Absorption of estrogens from vaginal creams
40. Biological effects of various doses of vaginally administered conjugated equine estrogen in postmenopausal women
41. Body size and breast cancer prognosis: A critical review of the evidence
42. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women